Please assess the completion status of the following clinical trial:

Trial Title: S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of Cirrhosis (Age 15 yr -70 yr )~Exclusion Criteria:~* Recent history of gastrointestinal bleed in last 6 weeks~* Active ongoing infection~* Creatinine \>1.5mg%~* Electrolyte impairment. (S. Sodium \< 130 meq/L, S. Potassium 3.5 meq/L or \>5.0meq/L)~* H/O use of psychotropic drugs in last 6 weeks~* Recent alcohol use (\< 6 week )~* H/O TIPS or shunt surgery.~* Hepatocellular Carcinoma~* Severe comorbidity as Congestive Heart Failure, Pulmonary disease, Neurological and Psychiatric problems impairing quality of life~* Poor vision precluding neuropsychological assessment

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Lactulose (Type: PLACEBO_COMPARATOR): Group L receives lactulose Group NL receives placebo
- Placebo (Type: PLACEBO_COMPARATOR): Group NL receives placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).